AZN P/E ratio: current value, 10-year range and year-by-year history
Cash & Leverage
AZN's p/e ratio is lower than 83% of the last 10 years.
P/E ratio History
AZN P/E ratio by year
Yearly range of AZN’s p/e ratio from 2016 to 2026. Over the full period it ranged from -217.8 to 486.1, averaging 41.2.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 13.2 | 22.7 | 32.0 | 24.6 |
| 2025 | 24.8 | 29.3 | 34.9 | 26.8 |
| 2024 | 28.8 | 35.9 | 42.4 | 28.8 |
| 2023 | 32.0 | 45.0 | 68.2 | 35.5 |
| 2022 | -217.8 | 40.6 | 486.1 | 104.0 |
| 2021 | 31.4 | 54.3 | 413.8 | 413.8 |
| 2020 | 41.4 | 75.7 | 99.7 | 41.4 |
| 2019 | 38.3 | 49.1 | 98.1 | 98.1 |
| 2018 | 26.5 | 34.4 | 44.7 | 44.7 |
| 2017 | 18.4 | 22.4 | 26.5 | 24.9 |
| 2016 | 25.7 | 30.4 | 39.5 | 27.8 |
Get notified when AZN P/E ratio crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.
Price / Earnings Per ShareThe chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.
- Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
- A falling P/E trend may signal a business in structural decline, not a buying opportunity.
Is AZN P/E ratio High or Low Right Now?
AstraZeneca PLC's P/E ratio is currently 24.6, which is historically cheap relative to its 10-year historical range. The 10-year median P/E ratio for AZN is approximately 35.7. See all AZN valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.